ACAD
ACADIA PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$19.80
+3.56%Forward multiples
Based on analyst estimates
- P/E forward
- 21.21x
- P/E 2026E
- 31.19x
- P/E 2027E
- 20.72x
- P/E 2028E
- 12.54x
- P/S forward
- 2.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- 8.80x
- PEG TTM
- —
- Price / book
- 2.61x
- Price / sales
- 3.00x
- Price / cash flow
- 17.56x
Enterprise value
- Enterprise value
- $2.5B
- EV / sales
- 2.22x
- EV / EBITDA
- 21.78x
- EV / EBIT
- 29.28x
- Market cap
- $3.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026